Johnson & Johnson’s boost its digital surgery portfolio acquiring Auris Health for $2.35bn

Johnson & Johnson [JNJ: NYSE] – Market Cap as of 19/02/2019 $364.53bn Introduction On February 13th, the healthcare giant Johnson & Johnson announced the acquisition of the privately held surgical robotics firm Auris Health, for approximately $3.4 billion in cash. The terms of the agreement also include additional payments to Read more…

Size matters: Bristol-Myers to acquire Celgene in one of the largest pharma deal in history for $74bn

Bristol-Myers Squibb Company (NYSE: BMY) – market cap as of 10/2/2019: $81.98bn Celgene Corporation (NASDAQ: CELG) – market cap as of 10/2/2019: $61.56bn Introduction On the 3rd of January 2019, Bristol-Myers Squibb Company (NYSE: BMY) announced the acquisition of Celgene Corporation (NASDAQ: CELG) in a cash and stock transaction with Read more…

Brookfield Business and CDPQ made the day of Johnson Controls’ Shareholders by acquiring Power Solution Business for $13.2bn

Johnson Control International PLC [JCI: NYSE] – Market Cap as of 21/11/2018 $30.754bn Brookfield Business Partners LP [BBU: NYSE] – Market Cap as of 21/11/2018 $4.613bn Introduction On November 13th, 2018 Johnson Control International announced its intentions to sell Power Solutions Business, one of its most profitable divisions. Generating $8bn Read more…